1. Krüppel-Like Factor 4 Inhibits the Transforming Growth Factor-β1-Promoted Epithelial-to-Mesenchymal Transition via Downregulating Plasminogen Activator Inhibitor-1 in Lung Epithelial Cells
    Fang Sun et al, 2015, Disease Markers CrossRef
  2. The Role of Krüppel-like Factor 4 in Renal Fibrosis
    Ben Ke et al, 2015, Front. Physiol. CrossRef
  3. Krüpple-like-factor 4 Attenuates Lung Fibrosis via Inhibiting Epithelial-mesenchymal Transition
    Lianjun Lin et al, 2017, Sci Rep CrossRef
  4. The critical role of Krüppel-like factors in kidney disease
    Sandeep K. Mallipattu et al, 2017, American Journal of Physiology-Renal Physiology CrossRef
  5. Role of the reprogramming factor KLF4 in blood formation
    Chun Shik Park et al, 2016, Journal of Leukocyte Biology CrossRef
  6. Transcription Factors as Therapeutic Targets in Chronic Kidney Disease
    Akihito Hishikawa et al, 2018, Molecules CrossRef
  7. Aberrant methylation of EYA4 promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma
    Mei Luo et al, 2018, Cancer Sci CrossRef
  8. MiR-139-5p suppresses osteosarcoma cell growth and invasion through regulating DNMT1
    Yong-Kang Shi et al, 2018, Biochemical and Biophysical Research Communications CrossRef
  9. Hypermethylated in cancer 1 (HIC1) mediates high glucose induced ROS accumulation in renal tubular epithelial cells by epigenetically repressing SIRT1 transcription
    Sheng Zeng et al, 2018, Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms CrossRef
  10. DNA methyltransferase 1 and Krüppel-like factor 4 axis regulates macrophage inflammation and atherosclerosis
    Run-Ze Tang et al, 2019, Journal of Molecular and Cellular Cardiology CrossRef
  11. Krϋppel-like factors (KLFs) in renal physiology and disease
    Madhavi J. Rane et al, 2019, EBioMedicine CrossRef
  12. Redox-fibrosis: Impact of TGFβ1 on ROS generators, mediators and functional consequences
    Kati Richter et al, 2015, Redox Biology CrossRef
  13. TGF-β: the master regulator of fibrosis.
    Xiao-Ming Meng et al, 2016, Nat Rev Nephrol CrossRef
  14. MicroRNA-212-3p inhibits the Proliferation and Invasion of Human Hepatocellular Carcinoma Cells by Suppressing CTGF expression
    Jian-qing Chen et al, 2019, Sci Rep CrossRef
  15. Kruppel-Like Transcription Factor-4 Gene Expression and DNA Methylation Status in Type 2 Diabetes and Diabetic Nephropathy Patients
    Zeynep Mine Coskun et al, 2019, Archives of Medical Research CrossRef
  16. TGF-β/Smad and Renal Fibrosis.
    Tao-Tao Ma et al, 2019, Adv Exp Med Biol CrossRef
  17. null
    Qian Yuan et al, 2019 CrossRef
  18. Epigenetic control of podocyte differentiation: a new target of the renin–angiotensin system in kidney disease
    Denis Feliers, 2015, Kidney International CrossRef
  19. Inhibitors of DNA methylation support TGF-β1-inducedIL11expression in gingival fibroblasts
    Irina-Georgeta Sufaru et al, 2017, J Periodontal Implant Sci CrossRef
  20. Kruppel‐like factor 4 improves obesity‐related nephropathy through increasing mitochondrial biogenesis and activities
    Lingwei Jin et al, 2019, J Cell Mol Med CrossRef
  21. Crosstalk between tubular epithelial cells and glomerular endothelial cells in diabetic kidney disease
    Si-Jie Chen et al, 2020, Cell Prolif CrossRef
  22. Exosomal miR‐103‐3p from LPS‐activated THP‐1 macrophage contributes to the activation of hepatic stellate cells
    Lisha Chen et al, 2020, FASEB j. CrossRef
  23. Long noncoding RNA LINC00673 epigenetically suppresses KLF4 by interacting with EZH2 and DNMT1 in gastric cancer.
    Ming-Chen Ba et al, 0 CrossRef
  24. Epigenetic Modifiers as Potential Therapeutic Targets in Diabetic Kidney Disease
    Julio M. Martinez-Moreno et al, 2020, IJMS CrossRef
  25. New Insights Into the Role and Mechanism of Partial Epithelial-Mesenchymal Transition in Kidney Fibrosis
    Lili Sheng et al, 2020, Front. Physiol. CrossRef
  26. HOXA10 promotion of HDAC1 underpins the development of lung adenocarcinoma through the DNMT1-KLF4 axis
    Tiangang Ma et al, 2021, J Exp Clin Cancer Res CrossRef
  27. Epigenetic regulation in fibrosis progress
    Taixiong Xue et al, 2021, Pharmacological Research CrossRef
  28. KLF4 Induces Mesenchymal–Epithelial Transition (MET) by Suppressing Multiple EMT-Inducing Transcription Factors
    Ayalur Raghu Subbalakshmi et al, 2021, Cancers CrossRef
  29. Antifibrotic factor KLF4 is repressed by the miR-10/TFAP2A/TBX5 axis in dermal fibroblasts: insights from twins discordant for systemic sclerosis
    Maya Malaab et al, 2021, Ann Rheum Dis CrossRef
  30. Epigenetic profiling of twins identify repression of KLF4 as a novel pathomechanism in systemic sclerosis
    Jörg H W Distler et al, 2021, Ann Rheum Dis CrossRef
  31. The applications of DNA methylation as a biomarker in kidney transplantation: a systematic review
    Iacopo Cristoferi et al, 2022, Clin Epigenet CrossRef
  32. DNMT3a negatively regulates PTEN to activate the PI3K/AKT pathway to aggravate renal fibrosis
    Taotao Hu et al, 2022, Cellular Signalling CrossRef
  33. The Histone Demethylase Inhibitor GSK-J4 Is a Therapeutic Target for the Kidney Fibrosis of Diabetic Kidney Disease via DKK1 Modulation
    Peir-Haur Hung et al, 2022, IJMS CrossRef
  34. Serum microRNAs in Systemic Sclerosis, Associations with Digital Vasculopathy and Lung Involvement
    Anna Wajda et al, 2022, IJMS CrossRef
  35. Low-dose 5-aza-2′-deoxycytidine protects against early renal injury by increasing klotho expression
    Yanlong Zhao et al, 2023, Epigenomics CrossRef
  36. Epigenetics as a versatile regulator of fibrosis
    Yangdan Liu et al, 2023, J Transl Med CrossRef
  37. Kidney fibrosis: from mechanisms to therapeutic medicines
    Rongshuang Huang et al, 2023, Sig Transduct Target Ther CrossRef
  38. Sp1-like protein KLF13 acts as a negative feedback regulator of TGF-β signaling and fibrosis
    Shu Yang et al, 2023, Cell Reports CrossRef
  39. KLF4 transcription factor in tumorigenesis
    Zhihong He et al, 2023, Cell Death Discov. CrossRef
  40. G9a and DNMT1 inhibition modulates CDKN1A promoter methylation and the cell cycle leading to improvement in kidney fibrosis
    Yuanyuan Yang et al, 2023, Biochimica et Biophysica Acta (BBA) - General Subjects CrossRef
  41. Targeting DNA methylation in diabetic kidney disease: A new perspective
    Vivek Akhouri et al, 2023, Life Sciences CrossRef
  42. Epigallocatechin‐3‐gallate attenuates arsenic‐induced fibrogenic changes in human kidney epithelial cells through reversal of epigenetic aberrations and antioxidant activities
    Mary Sonia Iheanacho et al, 2023, BioFactors CrossRef
  43. The progression of obstructive renal fibrosis in rats is regulated by ADAMTS18 gene methylation in the embryonic kidney through the AKT/Notch pathway
    Ben Xu et al, 2024, J Biochem & Molecular Tox CrossRef